Activity of erlotinib when dosed below the maximum...

Cancer 2016 / 08

Activity of erlotinib when dosed below the maximum tolerated dose for EGFR -mutant lung cancer: Implications for targeted therapy development

Lampson, Benjamin L., Nishino, Mizuki, Dahlberg, Suzanne E., Paul, Danie, Santos, Abigail A., Jänne, Pasi A., Oxnard, Geoffrey R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.30270
Date:
August, 2016
File:
PDF, 231 KB
english, 2016
Conversion to is in progress
Conversion to is failed